Skip to content

Comparison of painless, ultrafine and ordinary gastroscope endoangel-assisted blind spots: a prospective, single-blind, three-group, randomized, single-center trial

Comparison of painless, ultrafine and ordinary gastroscope endoangel-assisted blind spots: a prospective, single-blind, three-group, randomized, single-center trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020920
Enrollment
Unknown
Registered
2019-01-22
Start date
2019-01-18
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rate of Blind Spot in Gastroscopy

Interventions

6 groups:EndoAngel

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Males or females aged at least 18 years; 2) Gastroscopy is needed to further clarify the characteristics of digestive tract diseases; 3) Painless, ordinary and ultra-fine gastroscopy patients; 4) Able to read, understand and sign informed consent; 5) The investigator believes that the subjects can understand the clinical research process, are willing and able to complete all the research procedures and follow-up visits, and cooperate with the research procedures.

Exclusion criteria

Exclusion criteria: 1) Patiens have participated in other clinical trials, signed informed consent forms and were followed up in other clinical trials; 2) Patiens have participated in the clinical trial of the drug and during the eluting period of the experimental drug or the control drug; 3) drug or alcohol abuse or mental disorder in the last 5 years; 4) pregnant or lactating women; 5) subjects with previous history of gastric surgery or diagnosed with gastric stump; 6) allergic to preused anesthetic drugs was found in previous medical history; 7) prior history of spasmolytic agent allergy; 8) the investigator considers that the subject is not suitable for painless or general or ultrafine gastroscopy; 9) the investigator considers that the subjects are not suitable for high-risk diseases or other special circumstances of the clinical trial.

Design outcomes

Primary

MeasureTime frame
Blind spot rate;

Secondary

MeasureTime frame
Blind spot rate;Operation time;Comfort degree;Limb coordination;Vomiting reaction;

Countries

China

Contacts

Public ContactYu Honggang

Department of Gastroenterology, Renmin Hospital of Wuhan university

yuhonggang1968@163.com+86 13871281899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026